About
RocketVax develops next-generation live-attenuated virus vaccines for infectious diseases, focusing on nasal delivery of SARS-CoV-2 vaccines that offer broad and long-lasting immunity against current and emerging COVID-19 variants.
Explore RocketVax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.